Multilayered Defense in HLA-B51–Associated HIV Viral Control

Yonghong Zhang,Yanchun Peng,Hui‐ping Yan,Ke-yi Xu,M. Saito,Hao Wu,Xinyue Chen,S. Ranasinghe,N. Kuse,T. Powell,Yan Zhao,Wei-hua Li,Xin Zhang,Xia Feng,Ning Li,A. Leligdowicz,Xiaoning Xu,M. John,M. Takiguchi,A. McMichael,S. Rowland-Jones,T. Dong

DOI: https://doi.org/10.4049/jimmunol.1100316

2011-07-15

Abstract:Polymorphism in the HLA region of a chromosome is the major source of host genetic variability in HIV-1 outcome, but there is limited understanding of the mechanisms underlying the beneficial effect of protective class I alleles such as HLA-B57, -B27, and -B51. Taking advantage of a unique cohort infected with clade B’ HIV-1 through contaminated blood, in which many variables such as the length of infection, the infecting viral strain, and host genetic background are controlled, we performed a comprehensive study to understand HLA-B51–associated HIV-1 control. We focused on the T cell responses against three dominant HLA-B51–restricted epitopes: Gag327-345(NI9) NANPDCKTI, Pol743-751(LI9) LPPVVAKEI, and Pol283-289(TI8) TAFTIPSI. Mutations in all three dominant epitopes were significantly associated with HLA-B51 in the cohort. A clear hierarchy in selection of epitope mutations was observed through epitope sequencing. L743I in position 1 of epitope LI9 was seen in most B51+ individuals, followed by V289X in position 8 of the TI8, and then, A328S, in position 2 of the NI9 epitope, was also seen in some B51+ individuals. Good control of viral load and higher CD4+ counts were significantly associated with at least one detectable T cell response to unmutated epitopes, whereas lower CD4+ counts and higher viral loads were observed in patients who had developed escape mutations in all three epitopes or who lacked T cell responses specific to these epitope(s). We propose that patients with HLA-B51 benefit from having multiple layers of effective defense against the development of immune escape mutations.

Medicine